{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:00Z","timestamp":1793945400353,"version":"4.8.0"},"reference-count":267,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007846","name":"Yunnan Provincial Department of Education","doi-asserted-by":"publisher","award":["2024J0008"],"award-info":[{"award-number":["2024J0008"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32401125"],"award-info":[{"award-number":["32401125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124364","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:26:25Z","timestamp":1780719985000},"page":"124364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nanomedicine-enabled in situ vaccination: Advancing a trilogy of immunogenic cell death induction, antigen presentation potentiation, and microenvironment remodeling"],"prefix":"10.1016","volume":"335","author":[{"given":"Zhilin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-4241","authenticated-orcid":false,"given":"Ruibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib1","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41590-025-02308-2","article-title":"Cancer vaccines as enablers of immunotherapy","volume":"26","author":"Khleif","year":"2025","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124364_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104772","article-title":"The promise of mRNA vaccines in cancer treatment: technology, innovations, applications, and future directions","volume":"212","author":"Tang","year":"2025","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41591-026-04241-9","article-title":"Clinical development of cancer vaccines","volume":"32","author":"Haanen","year":"2026","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124364_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216846","article-title":"Immunogenic cell death inducers:current advances and future perspectives","volume":"542","author":"Lv","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124364_bib7","first-page":"498","article-title":"Advances in delivery technologies-powered cancer vaccines","volume":"61","author":"Huang","year":"2026","journal-title":"Bioact. Mater."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124364_bib8","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib9","article-title":"Recapitulating the cancer-immunity cycle on a chip","volume":"14","author":"Lee","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155485","article-title":"Tumor antigen presentation and the associated signal transduction during carcinogenesis","volume":"261","author":"Naskar","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib11","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.scib.2025.03.054","article-title":"T cell-based cancer immunotherapy: opportunities and challenges","volume":"70","author":"Ma","year":"2025","journal-title":"Sci. Bull."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124364_bib14","article-title":"Orchestrating cancer therapy: recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments","volume":"30","author":"Xu","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-025-01692-4","article-title":"Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy","volume":"18","author":"Liu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124364_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113721","article-title":"Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy","volume":"384","author":"Engelen","year":"2025","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib18","article-title":"Immunogenic cell death as a target for combination therapies in solid tumors: a systematic review toward a new paradigm in immuno-oncology","volume":"17","author":"Barjij","year":"2025","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300204","article-title":"Biomaterials that induce immunogenic cell death","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12951-025-03568-8","article-title":"A novel carrier-free nanoparticle with stable distinctive three-dimensional structure for tumor-targeted precision chemoimmunotherapy","volume":"23","author":"Deng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib22","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124364_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313097","article-title":"Dismantlable coronated nanoparticles for coupling the induction and perception of immunogenic cell death","volume":"36","author":"Liang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib24","first-page":"774","article-title":"Spatiotemporal activation of unfolded protein response by combined sonodynamic therapy and proteasome inhibition with bortezomib-conjugated TiN nanoparticles","volume":"61","author":"Yin","year":"2026","journal-title":"Bioact. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/0008-5472.CAN-10-2788","article-title":"Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis","volume":"71","author":"Schiavoni","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124364_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.75353","article-title":"Tyrosinase driven-intracellular polymerization of a porphyrin derivative induced immunogenic death of melanoma cells and strengthened photodynamic therapy","author":"Tang","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124364_bib27","doi-asserted-by":"crossref","unstructured":"H. Zhang, J. Lv, H. Wu, Y. He, M. Li, C. Wu, D. Lv, Y. Liu, H. Yang, Endogenous\/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy, Sci. Adv., 11(20), pp.eadq3870.","DOI":"10.1126\/sciadv.adq3870"},{"key":"10.1016\/j.biomaterials.2026.124364_bib28","article-title":"Engineering MnPt bimetallic nanozymes for Cascade enzymatic therapy and enhanced radio-immunotherapy","volume":"26","author":"Zhang","year":"2026","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41392-025-02355-z","article-title":"Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124364_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2025.200333","article-title":"Oncolytic virus and immunogenic cell death in cancer therapy","volume":"20","author":"Cao","year":"2025","journal-title":"Tumour Virus Res."},{"key":"10.1016\/j.biomaterials.2026.124364_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2026.102771","article-title":"An inhalable microbe-oncolytic virus consortium for lung cancer treatment","author":"Ling","year":"2026","journal-title":"Cell Rep. Med."},{"issue":"7549","key":"10.1016\/j.biomaterials.2026.124364_bib32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccell.2025.12.005","article-title":"Cancer cell death: cell-autonomous and immunogenic dimensions","volume":"44","author":"Galluzzi","year":"2026","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.2224","article-title":"Inflammasomes in carcinogenesis and anticancer immune responses","volume":"13","author":"Zitvogel","year":"2012","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"104","key":"10.1016\/j.biomaterials.2026.124364_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"Ben-Akiva","year":"2025","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/0115743624341069241112091959","article-title":"Revisiting the significance of TLRs: current understanding and future scope for therapeutic implications","volume":"20","author":"Singh","year":"2025","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.biomaterials.2026.124364_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113667","article-title":"Breaking the barriers in effective and safe toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapy","volume":"382","author":"Li","year":"2025","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124364_bib44","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.molcel.2025.08.030","article-title":"Activation and regulation of cGAS-STING signaling in cancer cells","volume":"85","author":"Shim","year":"2025","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2012STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib46","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1021\/acs.molpharmaceut.5c01263","article-title":"Targeting the cGAS-STING pathway for cancer immunotherapy: from small-molecule agonists to advanced nanomaterials","volume":"22","author":"Guo","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124364_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114957","article-title":"Engineering nanomedicine for STING pathway activation: advancing cancer immunotherapy","volume":"395","author":"Li","year":"2026","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib37","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.3390\/ijms24044253","article-title":"Dendritic cell and cancer therapy","volume":"24","author":"Galati","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124364_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123735","article-title":"Lymph node targeting nanomedicines for tumor immunotherapy","volume":"327","author":"Li","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124364_bib51","article-title":"Targeting lymph nodes for enhanced cancer vaccination: from nanotechnology to tissue engineering","volume":"26","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124364_bib52","article-title":"Lymph node-targeted nanomaterials for controlled nano-immunotherapy","volume":"7","author":"Zhao","year":"2025","journal-title":"Small Struct."},{"key":"10.1016\/j.biomaterials.2026.124364_bib53","article-title":"Strategies of designing lymph nodes-targeting nanoparticles for cancer immunotherapy","author":"Huang","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40820-023-01125-2","article-title":"Application of nano-delivery systems in lymph nodes for tumor immunotherapy","volume":"15","author":"Xia","year":"2023","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biomaterials.2026.124364_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41578-023-00552-2","article-title":"The protein corona from nanomedicine to environmental science","volume":"8","author":"Mahmoudi","year":"2023","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib56","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.apsb.2021.03.007","article-title":"Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124364_bib58","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1039\/D4CS00421C","article-title":"Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond","volume":"53","author":"Hsu","year":"2024","journal-title":"Chem. Soc. Rev."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124364_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304664","article-title":"Lymph node targeting mediated by albumin hitchhiking of synthetic Tn glycolipid leads to robust in vivo antibody production","volume":"13","author":"Thekke Veettil","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"33","key":"10.1016\/j.biomaterials.2026.124364_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402199","article-title":"Dendritic cell-hitchhiking in vivo for vaccine delivery to lymph nodes","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci."},{"issue":"33","key":"10.1016\/j.biomaterials.2026.124364_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302423","article-title":"Dendritic cell-mimicking nanoparticles promote mRNA delivery to lymphoid organs","volume":"10","author":"Cao","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41419-025-07544-w","article-title":"Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application","volume":"16","author":"Pan","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biomaterials.2026.124364_bib63","series-title":"Encyclopedia of Immunobiology","first-page":"594","article-title":"Myeloid-derived suppressor cells in cancer","author":"Mohd Jaya","year":"2026"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib67","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib71","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib72","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.32604\/or.2025.071708","article-title":"CD47-Targeted therapy in cancer immunotherapy: at a crossroads of promise and challenge","volume":"33","author":"Guo","year":"2025","journal-title":"Oncol. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib73","article-title":"CD47 as a potent target in cancer immunotherapy: a review","volume":"1880","author":"Ahvati","year":"2025","journal-title":"BBA-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib74","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-025-07984-4","article-title":"TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Differ."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124364_bib75","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2174\/0929867330666230324152532","article-title":"CD155-TIGIT axis as a therapeutic target for cancer immunotherapy","volume":"31","author":"Mu","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124364_bib76","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1021\/acs.jmedchem.5c02693","article-title":"TIM-3 inhibitor development: overcoming immune evasion in cancer therapy","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"93","key":"10.1016\/j.biomaterials.2026.124364_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf2223","article-title":"Beyond T cell exhaustion: TIM-3 regulation of myeloid cells","volume":"9","author":"Dixon","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117141","article-title":"Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020\u20132024)","volume":"283","author":"Cheng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib79","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.apsb.2025.04.002","article-title":"Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy","volume":"15","author":"Jiang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124364_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib82","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124364_bib83","doi-asserted-by":"crossref","first-page":"102461","DOI":"10.1016\/j.ctrv.2022.102461","article-title":"Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy","volume":"110","author":"Fujiwara","year":"2022","journal-title":"Cancer Treat Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70703","article-title":"The kynurenine pathway and indole pathway in tryptophan metabolism influence tumor progression","volume":"14","author":"Lu","year":"2025","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib85","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","article-title":"The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","article-title":"Same yet different - how lymph node heterogeneity affects immune responses","volume":"24","author":"Cruz de Casas","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.actbio.2024.12.039","article-title":"Impact of nanoparticle properties on immune cell interactions in the lymph node","volume":"193","author":"Farooq","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218076","article-title":"Tumor microenvironment and macroenvironment: a new perspective on holistic oncology","volume":"634","author":"Chen","year":"2025","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124364_bib88","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1021\/jacs.3c14005","article-title":"Nanomedicine remodels tumor microenvironment for solid tumor immunotherapy","volume":"146","author":"Guo","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib90","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124364_bib92","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.3390\/ijms24108871","article-title":"Targeting immunosuppressive adenosine signaling: a review of potential immunotherapy combination strategies","volume":"24","author":"Zahavi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124364_bib93","doi-asserted-by":"crossref","first-page":"20418","DOI":"10.1039\/D5RA02235E","article-title":"Therapeutic potential of adenosine receptor modulators in cancer treatment","volume":"15","author":"Maity","year":"2025","journal-title":"RSC Adv."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124364_bib94","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1039\/D5NA00390C","article-title":"Nanomedicine revolutionizing cancer immunotherapy: recent advancements in nanotechnological strategies and applications","volume":"7","author":"Bhatt","year":"2025","journal-title":"Nanoscale Adv."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124364_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib96","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.apsb.2024.05.010","article-title":"Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124364_bib97","first-page":"299","article-title":"A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody","volume":"21","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202413603","article-title":"Advanced polymeric nanoparticles for cancer immunotherapy: materials engineering, immunotherapeutic mechanism and clinical translation","volume":"37","author":"Jia","year":"2025","journal-title":"Adv. Mater."},{"issue":"40","key":"10.1016\/j.biomaterials.2026.124364_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202513567","article-title":"Tumor microenvironment-responsive nanomedicines for potentiating cancer immunotherapy","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/imr.13237","article-title":"Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy","volume":"321","author":"Xu","year":"2024","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib104","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2219591","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in oncology","volume":"12","author":"Sprooten","year":"2023","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","article-title":"Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches","volume":"22","author":"Sheibani","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib106","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1038\/s41467-022-33831-7","article-title":"In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses","volume":"13","author":"Guo","year":"2022","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124364_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501542","article-title":"Mitoxantrone-encapsulated ZIF-8 enhances chemo-immunotherapy via amplified immunogenic cell death","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124364_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300286","article-title":"In situ vaccination with mitochondria-targeting immunogenic death inducer elicits CD8(+) T cell-dependent antitumor immunity to boost tumor immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124364_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102335","article-title":"Cationic lipid-polymer hybrid nanoparticle drives in situ generation and lymphatic navigation of tumor antigens to prime systemic antitumor immunity","volume":"57","author":"Chen","year":"2024","journal-title":"Nano Today"},{"issue":"47","key":"10.1016\/j.biomaterials.2026.124364_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202514530","article-title":"Molecular recognition driven organelle cross-linking induces endoplasmic reticulum stress and mitochondrial dysfunction to potentiate cancer immunotherapy","volume":"64","author":"Tang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"36","key":"10.1016\/j.biomaterials.2026.124364_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202205701","article-title":"A self-reporting fluorescent salicylaldehyde-chlorambucil conjugate as a Type-II ICD inducer for cancer vaccines","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124364_bib109","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100871","article-title":"Redox signals at the ER-mitochondria interface control melanoma progression","volume":"38","author":"Zhang","year":"2019","journal-title":"EMBO J."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124364_bib110","doi-asserted-by":"crossref","first-page":"28047","DOI":"10.1021\/acsami.0c08112","article-title":"Cationic Liposome\/DNA complexes mediate antitumor immunotherapy by promoting immunogenic tumor cell death and dendritic cell activation","volume":"12","author":"Cong","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.603","article-title":"Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies","volume":"5","author":"Zhao","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.biomaterials.2026.124364_bib112","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41563-026-02506-9","article-title":"In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy","volume":"25","author":"Chen","year":"2026","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib125","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1038\/s41467-024-49156-6","article-title":"Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124364_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123634","article-title":"Multimodal cascade-amplified phototheranostics for enhanced anti-tumor immunity","volume":"325","author":"Chen","year":"2026","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib113","doi-asserted-by":"crossref","first-page":"109957","DOI":"10.1016\/j.cclet.2024.109957","article-title":"Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: alleviating, exploiting and disregarding","volume":"36","author":"Jia","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2026.124364_bib114","doi-asserted-by":"crossref","first-page":"163962","DOI":"10.1016\/j.cej.2025.163962","article-title":"Emerging tumor hypoxia-relieving nanotherapeutics for boosting photodynamic therapy","volume":"516","author":"Yang","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124364_bib115","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib116","doi-asserted-by":"crossref","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124364_bib117","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14728222.2023.2261631","article-title":"OXPHOS-targeting drugs in oncology: new perspectives","volume":"27","author":"Kalyanaraman","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124364_bib118","doi-asserted-by":"crossref","first-page":"21170","DOI":"10.1021\/acsnano.3c05034","article-title":"\"Closed-Loop\" O(2)-Economizer induced in situ therapeutic vaccine against hypoxic tumors","volume":"17","author":"Zhao","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib119","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsabm.4c01820","article-title":"Photothermal-therapy-based targeting thrombolytic therapy","volume":"8","author":"Zhang","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The extracellular matrix in cancer: from understanding to targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biomaterials.2026.124364_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113786","article-title":"Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance","volume":"383","author":"Ding","year":"2025","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124364_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202200993","article-title":"Deep tumor penetrating gold nano-adjuvant for NIR-II-Triggered in situ tumor vaccination","volume":"18","author":"Chen","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124364_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.30683\/1927-7229.2024.13.02","article-title":"New insights on hyperbaric oxygen therapy for cancer","volume":"13","author":"Gonz\u00e1lez","year":"2024","journal-title":"J. Anal. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib124","article-title":"Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity","volume":"3","author":"Ortmann","year":"2024","journal-title":"BMJ Oncol"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib127","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124364_bib128","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1021\/acsnano.4c01600","article-title":"Self-adaptive photodynamic-to-photothermal switch for smart antitumor photoimmunotherapy","volume":"18","author":"Yu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmst.2022.08.049","article-title":"Gallium-based liquid metal micro\/nanoparticles for photothermal cancer therapy","volume":"142","author":"Mingming Fu","year":"2023","journal-title":"J. Mater. Sci. Technol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113888","article-title":"Recent advances and progress on the design, fabrication and biomedical applications of Gallium liquid metals-based functional materials","volume":"238","author":"Huang","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124364_bib131","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1021\/acsnano.3c00941","article-title":"Liquid metal nanoplatform based autologous cancer vaccines","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib132","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1021\/acsnano.5c02753","article-title":"Ultrasmall Bi@Au schottky heterojunction with a high potential barrier for amplifying radioimmunotherapy","volume":"19","author":"Shen","year":"2025","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib133","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232101","article-title":"Radiotherapy and immunology","volume":"221","author":"Wang","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124364_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2024.102460","article-title":"Shaping DNA damage responses: therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer","volume":"76","author":"Ng","year":"2024","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104658","article-title":"The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy","volume":"209","author":"Jiang","year":"2025","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib138","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib136","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1021\/acsnano.4c13320","article-title":"Orthogonally engineered bacteria capture metabolically labeled tumor antigens to improve the systemic immune response in irradiated tumors","volume":"19","author":"Xia","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib137","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/s41467-024-48423-w","article-title":"Chiral coordination polymer nanowires boost radiation-induced in situ tumor vaccination","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib139","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1039\/D1TB02524D","article-title":"Multifunctional high-Z nanoradiosensitizers for multimodal synergistic cancer therapy","volume":"10","author":"Chen","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib140","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.7150\/thno.84500","article-title":"Immunogenic radiation therapy for enhanced anti-tumor immunity via core-shell nanocomposite-mediated multiple strategies","volume":"13","author":"Huang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124364_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218183","article-title":"Overcoming radioresistance in prostate cancer by targeting DNA damage repair","volume":"639","author":"Matos","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124364_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2026.217693","article-title":"Rational molecular design and emerging applications of small-molecule sonosensitizers for sonodynamic therapy","volume":"556","author":"Guo","year":"2026","journal-title":"Coord. Chem. Rev."},{"issue":"30","key":"10.1016\/j.biomaterials.2026.124364_bib144","doi-asserted-by":"crossref","first-page":"27804","DOI":"10.1021\/acsnano.5c08928","article-title":"Noninvasive activation of local and systemic immunity with a sequential-targeting sonodynamic nanovaccine to treat glioblastoma","volume":"19","author":"Cheng","year":"2025","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202413289","article-title":"Cryo-shocked tumor-reprogrammed sonosensitive antigen-presenting cells improving sonoimmunotherapy via T cells and NK cells immunity","volume":"37","author":"Qian","year":"2025","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124364_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407914","article-title":"Sulfate radical based in situ vaccine boosts systemic antitumor immunity via concurrent activation of necroptosis and STING pathway","volume":"36","author":"Huang","year":"2024","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib151","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41565-024-01826-8","article-title":"Autophagosomes coated in situ with nanodots act as personalized cancer vaccines","volume":"20","author":"Huang","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib146","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/acsnano.3c11436","article-title":"An oral nanomedicine elicits in situ vaccination effect against colorectal cancer","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202410338","article-title":"Transition metal complex-loaded nanosystems: advances in stimuli-responsive cancer therapies","volume":"21","author":"Das","year":"2025","journal-title":"Small"},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124364_bib148","article-title":"Endoplasmic reticulum-targeting Iridium(III) nanosonosensitizer amplifies immunogenic cell death for boosted tumor sono-immunotherapy","volume":"34","author":"Xu","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124364_bib149","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1021\/acsnano.3c11023","article-title":"Bioorthogonal\/ultrasound activated oncolytic pyroptosis amplifies in situ tumor vaccination for boosting antitumor immunity","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124364_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302250","article-title":"Advanced oxidation nanoprocessing boosts immunogenicity of whole tumor cells","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"issue":"52","key":"10.1016\/j.biomaterials.2026.124364_bib153","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1021\/jacs.0c09482","article-title":"Na(2)S(2)O(8) nanoparticles trigger antitumor immunotherapy through reactive oxygen species storm and surge of tumor osmolarity","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib154","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cells12040668","article-title":"Autophagosome biogenesis","volume":"12","author":"Zhen","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/1873-3468.14742","article-title":"Structural view on autophagosome formation","volume":"598","author":"Noda","year":"2024","journal-title":"FEBS Lett."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124364_bib156","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1158\/1078-0432.CCR-11-0951","article-title":"Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy","volume":"17","author":"Li","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206411","article-title":"Manipulation of PD-L1 endosomal trafficking promotes anticancer immunity","volume":"10","author":"Ye","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib158","first-page":"151","article-title":"Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1","volume":"6","author":"Wen","year":"2018","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib159","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib161","first-page":"924","article-title":"Biomaterials nanoplatform-based tumor vaccines for immunotherapy","volume":"51","author":"Li","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102460","article-title":"Rethinking toll-like receptor signalling","volume":"91","author":"Bryant","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"42","key":"10.1016\/j.biomaterials.2026.124364_bib166","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1039\/D4CC00792A","article-title":"Molecule engineering strategy of toll-like receptor 7\/8 agonists designed for potentiating immune stimuli activation","volume":"60","author":"Gu","year":"2024","journal-title":"Chem. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib162","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2025.94907642","article-title":"NanoAlum based delivery system to formulate in-situ vaccine for personalized breast cancer immunotherapy","volume":"18","author":"Li","year":"2025","journal-title":"Nano Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418583","article-title":"DNA-capturing manganese-coordinated chitosan microparticles potentiate radiotherapy via activating the cGAS-STING pathway and maintaining tumor-infiltrating CD8+ T-Cell stemness","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124364_bib164","doi-asserted-by":"crossref","first-page":"12194","DOI":"10.1021\/acsnano.4c00413","article-title":"Engineered bacteriophage-based in situ vaccine remodels a tumor microenvironment and elicits potent antitumor immunity","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib167","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/acsnano.3c10225","article-title":"Radiotherapy-triggered in situ tumor vaccination boosts checkpoint blockaded immune response via antigen-capturing nanoadjuvants","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib168","first-page":"1142","article-title":"Regulation of the cGAS-STING pathway","volume":"17","author":"Zhang","year":"2025","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib169","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41401-023-01210-7","article-title":"Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124364_bib170","doi-asserted-by":"crossref","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","article-title":"Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for cancer immunotherapy","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib171","doi-asserted-by":"crossref","first-page":"158","DOI":"10.34133\/bmr.0158","article-title":"Mechanisms and applications of manganese-based nanomaterials in tumor diagnosis and therapy","volume":"29","author":"Ma","year":"2025","journal-title":"Biomater. Res."},{"issue":"38","key":"10.1016\/j.biomaterials.2026.124364_bib172","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn3002","article-title":"Hybrid nanoparticle-mediated simultaneous ROS scavenging and STING activation improve the antitumor immunity of in situ vaccines","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124364_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121763","article-title":"Hybrid M13 bacteriophage-based vaccine platform for personalized cancer immunotherapy","volume":"289","author":"Dong","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124364_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: a critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.ai.2023.07.001","article-title":"MHC cross-dressing in antigen presentation","volume":"159","author":"MacNabb","year":"2023","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib176","first-page":"148","volume":"6","author":"Qiu","year":"2023"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124364_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1244","article-title":"In situ cancer vaccination using lipidoid nanoparticles","volume":"7","author":"Chen","year":"2021","journal-title":"Sci. Adv."},{"issue":"32","key":"10.1016\/j.biomaterials.2026.124364_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203100","article-title":"In situ antigen-capturing nanochaperone toward personalized nanovaccine for cancer immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124364_bib182","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3389\/fimmu.2019.00775","article-title":"Metabolic control of dendritic cell functions: digesting information","volume":"10","author":"Wculek","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib183","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2009.06.022","article-title":"A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells","volume":"31","author":"Bougn\u00e8res","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib184","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124364_bib185","doi-asserted-by":"crossref","first-page":"24947","DOI":"10.1021\/acsnano.3c06784","article-title":"Dendritic cell-based in situ nanovaccine for reprogramming lipid metabolism to boost tumor immunotherapy","volume":"17","author":"Qin","year":"2023","journal-title":"ACS Nano"},{"issue":"105","key":"10.1016\/j.biomaterials.2026.124364_bib186","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5570","article-title":"Immunogenomic cancer evolution: a framework to understand cancer immunosuppression","volume":"10","author":"Kumagai","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.105057","article-title":"The role of MHC molecules in cancer immunotherapy: insights into tumor immune evasion and therapeutic strategies","volume":"218","author":"Huang","year":"2026","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154688","article-title":"Epigenetic drugs as new emerging therapeutics: what is the scale's orientation of application and challenges?","volume":"248","author":"Farani","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"31","key":"10.1016\/j.biomaterials.2026.124364_bib179","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1021\/acsnano.4c04045","article-title":"Ultrasound-activatable in situ vaccine for enhanced antigen Self- and cross-presentation to overcome cancer immunotherapy resistance","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124364_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305832","article-title":"In situ hydrogel modulates cDC1-Based antigen presentation and cancer stemness to enhance cancer vaccine efficiency","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci."},{"issue":"31","key":"10.1016\/j.biomaterials.2026.124364_bib181","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx6732","article-title":"Morphology- and adhesion-dual biomimetic nanovaccine boosts antigen cross-presentation through subcellular transport regulation","volume":"11","author":"Wang","year":"2025","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib189","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"103","key":"10.1016\/j.biomaterials.2026.124364_bib190","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: how dendritic cells shape CD8(+) T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305081","article-title":"Engineered probiotic-based personalized cancer vaccine potentiates antitumor immunity through initiating trained immunity","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124364_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2025.100128","article-title":"Nanoparticles engineering strategies for lymph-node targeted cancer immunotherapy","volume":"11","author":"Chandpa","year":"2025","journal-title":"Nano Trends"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib196","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.apsb.2024.06.003","article-title":"In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124364_bib193","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.7150\/thno.114347","article-title":"NIR-II light-driven in situ nanovaccine for cancer immunotherapy via lymph node migration-mediated accumulation","volume":"15","author":"Huang","year":"2025","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib194","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1021\/acsnano.3c11189","article-title":"Antigen self-presented personalized nanovaccines boost the immunotherapy of highly invasive and metastatic tumors","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib195","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jconrel.2025.01.087","article-title":"An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy","volume":"379","author":"Zhang","year":"2025","journal-title":"J. Contr. Release"},{"issue":"50","key":"10.1016\/j.biomaterials.2026.124364_bib197","doi-asserted-by":"crossref","first-page":"34063","DOI":"10.1021\/acsnano.4c09653","article-title":"Biomimetic dendritic cell-based nanovaccines for reprogramming the immune microenvironment to boost tumor immunotherapy","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib198","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","article-title":"Lymphatic targeting by albumin-hitchhiking: applications and optimisation","volume":"327","author":"Abdallah","year":"2020","journal-title":"J. Contr. Release"},{"issue":"29","key":"10.1016\/j.biomaterials.2026.124364_bib199","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211055","article-title":"Albumin-hitchhiking drug delivery to tumor-draining lymph nodes precisely boosts tumor-specific immunity through autophagy modulation of immune cells","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning cold tumors into hot tumors to ignite immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib201","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41568-025-00832-9","article-title":"Regulatory T cells in the tumour microenvironment","volume":"25","author":"Imianowski","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104995","article-title":"Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma","volume":"25","author":"Webb","year":"2022","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124364_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201906922","article-title":"In situ formed fibrin scaffold with cyclophosphamide to synergize with immune checkpoint blockade for inhibition of cancer recurrence after surgery","volume":"30","author":"Zhang","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib206","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib207","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41416-023-02230-0","article-title":"Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner","volume":"128","author":"Mao","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib208","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00262-023-03497-1","article-title":"BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy","volume":"72","author":"Sun","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"33","key":"10.1016\/j.biomaterials.2026.124364_bib204","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302508","article-title":"Augmenting immunogenic cell death and alleviating myeloid-derived suppressor cells by sono-activatable semiconducting polymer nanopartners for immunotherapy","volume":"35","author":"Ding","year":"2023","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202512230","article-title":"Multichannel immune nanoregulators suppress lactic acid metabolism and lactic acid-shaped acidic microenvironment to uproot anti-tumor immunosuppression","volume":"38","author":"Fang","year":"2026","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib209","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.apsb.2025.07.021","article-title":"Understanding the complexity of tumor-associated macrophages: druggable and therapeutic insights","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124364_bib210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2021.11.028","article-title":"Nanomaterials targeting tumor associated macrophages for cancer immunotherapy","volume":"341","author":"Zhao","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124364_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102104","article-title":"TAM-preferential nanoparticles intracellularly self-assembled for enhanced macrophage repolarization and cancer immunotherapy","volume":"54","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124364_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296341","article-title":"PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment","volume":"14","author":"Parvez","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib213","first-page":"285","article-title":"NIR-II photo-accelerated polymer nanoparticles boost tumor immunotherapy via PD-L1 silencing and immunogenic cell death","volume":"46","author":"Zhang","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102678","article-title":"An immunogenic cell death dual-nanoamplifier for the reverse of chemotherapy resistance and immune escape in metastatic colon cancer","volume":"62","author":"Zhang","year":"2025","journal-title":"Nano Today"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124364_bib215","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418053","article-title":"Engineered bacterial outer membrane vesicles-based doxorubicin and CD47-siRNA Co-Delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma","volume":"37","author":"You","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib216","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s12951-025-03875-0","article-title":"Tumor targeting dendritic nanocarrier with immunogenic cell death inducing and TIGIT blockade for synergistic chemo-immunotherapy against TNBC","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124364_bib217","doi-asserted-by":"crossref","first-page":"691","DOI":"10.32604\/or.2023.030767","article-title":"Codelivery of anti-CD47 antibody and chlorin e6 using a dual pH-sensitive nanodrug for photodynamic immunotherapy of osteosarcoma","volume":"32","author":"Xiao","year":"2024","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib218","article-title":"Cancer vaccine from intracellularly gelated tumor cells functionalized with CD47 blockage and damage-associated molecular pattern exposure","volume":"6","author":"Gao","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib219","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1021\/acs.jmedchem.1c00599","article-title":"Discovery of RRx-001, a myc and CD47 downregulating small molecule with tumor targeted cytotoxicity and healthy tissue cytoprotective properties in clinical development","volume":"64","author":"Oronsky","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib220","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1021\/acs.molpharmaceut.4c00254","article-title":"Photodynamic therapy synergizes CD47 blockade strategy for enhanced antitumor therapy","volume":"21","author":"Fu","year":"2024","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124364_bib221","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00262-025-04128-7","article-title":"Anti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanisms","volume":"74","author":"Sundstrom","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124364_bib222","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300171","article-title":"In situ STING-activating nanovaccination with TIGIT blockade for enhanced immunotherapy of Anti-PD-1-Resistant tumors","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124364_bib223","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5518","article-title":"Effects of glycolysis on the polarization and function of tumor-associated macrophages","volume":"62","author":"Cao","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114587","article-title":"Nanomedicine-mediated modulation of tumor metabolism for enhanced immunotherapy","volume":"390","author":"Liu","year":"2026","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124364_bib225","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419033","article-title":"Glucose metabolism-targeted poly(amino acid) nanoformulation of Oxaliplatin(IV)-Aspirin prodrug for enhanced chemo-immunotherapy","volume":"37","author":"Yang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124364_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122934","article-title":"Bimetallic peroxide-based nanotherapeutics for immunometabolic intervention and induction of immunogenic cell death to augment cancer immunotherapy","volume":"315","author":"Han","year":"2025","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.biomaterials.2026.124364_bib227","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202405673","article-title":"Interference of ATP-adenosine axis by engineered biohybrid for amplifying immunogenic cell death-mediated antitumor immunotherapy","volume":"36","author":"Deng","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2026.124364_bib229","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2021.05.034","article-title":"Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy","volume":"335","author":"Xia","year":"2021","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124364_bib230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/ijms26020610","article-title":"The pentose phosphate pathway: from mechanisms to implications for gastrointestinal cancers","volume":"26","author":"Qiao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124364_bib231","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202109726","article-title":"High-Z-Sensitized radiotherapy synergizes with the intervention of the pentose phosphate pathway for in situ tumor vaccination","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib232","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","article-title":"Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer","volume":"23","author":"Yan","year":"2024","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib233","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1021\/acsnano.2c11964","article-title":"Paraptosis inducer to effectively trigger immunogenic cell death for metastatic tumor immunotherapy with IDO inhibition","volume":"17","author":"Zheng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124364_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111281","article-title":"Metabolic crosstalk: extracellular ATP and the tumor microenvironment in cancer progression and therapy","volume":"121","author":"Shukla","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biomaterials.2026.124364_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123216","article-title":"Immunity\/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12\/CXCR4 and adenosine-A2AR pathways","volume":"319","author":"Wei","year":"2025","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib236","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cac2.12596","article-title":"Dysfunction of dendritic cells in tumor microenvironment and immunotherapy","volume":"44","author":"Chen","year":"2024","journal-title":"Cancer Commun."},{"issue":"5808","key":"10.1016\/j.biomaterials.2026.124364_bib237","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"issue":"6774","key":"10.1016\/j.biomaterials.2026.124364_bib238","doi-asserted-by":"crossref","DOI":"10.1126\/science.ady5362","article-title":"Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity","volume":"390","author":"Xie","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124364_bib239","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.11.002","article-title":"Harnessing the potential of CD40 agonism in cancer therapy","volume":"75","author":"Zhou","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biomaterials.2026.124364_bib240","first-page":"1","article-title":"DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions","author":"Michael","year":"2026","journal-title":"Epigenomics"},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124364_bib241","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1021\/acs.jmedchem.4c01912","article-title":"Targeting HMGB1 and its interaction with receptors: challenges and future directions","volume":"67","author":"Shen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124364_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216494","article-title":"HMGB1 in the interplay between autophagy and apoptosis in cancer","volume":"581","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib243","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s10020-021-00307-1","article-title":"Redox modifications of cysteine residues regulate the cytokine activity of HMGB1","volume":"27","author":"Yang","year":"2021","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124364_bib244","article-title":"Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"9","author":"Hubert","year":"2021","journal-title":"J. Immunother."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib245","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41596-022-00709-3","article-title":"The cell-line-derived subcutaneous tumor model in preclinical cancer research","volume":"17","author":"Stribbling","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2026.124364_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib247","article-title":"Application of in vitro and in vivo cancer models to study the impact of the tumor immune microenvironment on anticancer therapy","volume":"1881","author":"Gupta","year":"2026","journal-title":"BBA-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib248","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-immunol-082223-041615","article-title":"T cell development and responses in human immune system mice","volume":"43","author":"Khosravi-Maharlooei","year":"2025","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib249","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41592-025-02769-1","article-title":"From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research","volume":"22","author":"Rauner","year":"2025","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12943-025-02479-4","article-title":"Advances in engineering immune\u2013tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery","volume":"24","author":"Dabbagh Moghaddam","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124364_bib251","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tibtech.2023.11.006","article-title":"Converging bioprinting and organoids to better recapitulate the tumor microenvironment","volume":"42","author":"Wang","year":"2024","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib252","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","article-title":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib253","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124364_bib254","doi-asserted-by":"crossref","first-page":"eadx1576","DOI":"10.1126\/sciadv.adx1576","article-title":"The evolution of nanomedicine: the rise of next-generation nanomaterials in cancer nanomedicine","volume":"11","author":"Forgham","year":"2025","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124364_bib255","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib256","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib257","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124364_bib258","article-title":"Inorganic nanoparticles as smart carriers for docetaxel delivery in cancer therapy: mechanisms, targeting strategies, and translational insights","volume":"114","author":"Jameel","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biomaterials.2026.124364_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2026.100444","article-title":"Cell membrane-engineered biomimetic nanoparticles: exploiting the nano-biointerface for medical applications","author":"Zahid","year":"2026","journal-title":"Cell Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib260","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124364_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmed.2026.100002","article-title":"Nanocarrier-induced inflammation: mechanisms, immunometabolic impacts and strategies for safer design","volume":"1","author":"Sahu","year":"2026","journal-title":"TransMed"},{"key":"10.1016\/j.biomaterials.2026.124364_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123267","article-title":"Progressive tools and critical strategies for development of best fit PBPK model aiming better in Vitro\u2013in vivo correlation","volume":"643","author":"Golhar","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124364_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104448","article-title":"Revolutionizing drug discovery: integrating artificial intelligence with quantitative systems pharmacology","volume":"30","author":"Goryanin","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2026.124364_bib264","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2025.105576","article-title":"Spatial multi-omics technologies and applications in cancer","volume":"257","author":"Ji","year":"2025","journal-title":"Biosystems"},{"key":"10.1016\/j.biomaterials.2026.124364_bib265","article-title":"Recent advances in cancer nanomedicine: from smart targeting to personalized therapeutics - pioneering a new era in precision oncology","volume":"36","author":"Younas","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124364_bib266","article-title":"Machine learning reshapes the paradigm of nanomedicine research","author":"Wei","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"42","key":"10.1016\/j.biomaterials.2026.124364_bib267","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202510239","article-title":"Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery","volume":"37","author":"Bae","year":"2025","journal-title":"Adv. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:11:11Z","timestamp":1785888671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226003881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":267,"alternative-id":["S0142961226003881"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124364","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine-enabled in situ vaccination: Advancing a trilogy of immunogenic cell death induction, antigen presentation potentiation, and microenvironment remodeling","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124364"}}